Publisher investigating “serious concerns” about article on ivermectin, COVID, and the microbiome

The publisher Frontiers has published an expression of concern for an article that proposed “ivermectin protects against COVID-19” via effects on the microbiome.   The article, “Microbiome-Based Hypothesis on Ivermectin’s Mechanism in COVID-19: Ivermectin Feeds Bifidobacteria to Boost Immunity,” was published in July 2022 in Frontiers in Microbiology. The sole author, Sabine Hazan, is affiliated with … Continue reading Publisher investigating “serious concerns” about article on ivermectin, COVID, and the microbiome

Journal says ivermectin study met standard for ‘credible science’

A journal editor is defending his decision to publish a new paper showing that ivermectin can prevent Covid-19, despite more than a dozen retractions of such papers from the literature. The article, “Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results … Continue reading Journal says ivermectin study met standard for ‘credible science’

Weekend reads: Retracted papers that keep getting cited; ivermectin retractions; publishing peer reviews

Would you consider a donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Japanese university recommends five retractions after investigating botany researcher ‘Our deepest apology’: Journal retracts 30 likely paper mill articles after investigation published by Retraction Watch Our list of retracted or withdrawn COVID-19 papers is up to … Continue reading Weekend reads: Retracted papers that keep getting cited; ivermectin retractions; publishing peer reviews

Widely touted abstract on ivermectin and COVID-19 retracted

The authors of a controversial meeting abstract linking ivermectin to lower mortality from Covid-19 have retracted the study, saying that the work has been widely “misinterpreted” and might be leading to patient harm.  The abstract, “Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients: Analysis of a National Federated Database,” was presented at … Continue reading Widely touted abstract on ivermectin and COVID-19 retracted

Another ivermectin-COVID-19 paper is retracted

A paper on the potential use of ivermectin to treat Covid-19 has been retracted for a litany of flaws, joining at least 10 other articles on the therapy some liked to promote without evidence to fall.  The article was part of a special issue of Toxicology Reports on Covid-19 that has received an expression of … Continue reading Another ivermectin-COVID-19 paper is retracted

Ivermectin papers slapped with expressions of concern

A journal has issued expressions of concern for a pair of 2021 meta-analyses purporting to find that ivermectin is an effective treatment for Covid-19 after data sleuths raised questions about some of the research in the studies.  As we reported last fall, one of the two papers – “Ivermectin for Prevention and Treatment of COVID-19 … Continue reading Ivermectin papers slapped with expressions of concern

Paper used to support claims that ivermectin reduces COVID-19 hospitalizations is withdrawn by preprint server

The overseers of the preprint server SocArXiv have withdrawn a paper which claims that treating Covid patients with ivermectin dramatically reduces their odds of hospitalization, calling the work “misleading” and “part of an unethical program by the government of Mexico City to dispense hundreds of thousands of doses of an inappropriate medication to people who … Continue reading Paper used to support claims that ivermectin reduces COVID-19 hospitalizations is withdrawn by preprint server

How an ivermectin study that didn’t mention COVID-19 fell under scrutiny

A PLOS journal has issued an expression of concern for a 2018 paper which claimed that ivermectin could be useful as a way to control dengue fever.  In fact, the reason the journal re-examined the article was because the hype about the use of ivermectin for Covid-19 led at least one skeptic to take a … Continue reading How an ivermectin study that didn’t mention COVID-19 fell under scrutiny

Weekend reads: ‘Fraudulent and faulty research;’ a $275K settlement — but resignation — for a professor; ‘COVID-19, ivermectin, and beyond’

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Exercise researcher earns more retractions as investigations mount Another setback … Continue reading Weekend reads: ‘Fraudulent and faulty research;’ a $275K settlement — but resignation — for a professor; ‘COVID-19, ivermectin, and beyond’

Ivermectin-COVID-19 study retracted; authors blame file mixup

The authors of a study purportedly showing that ivermectin could treat patients with  SARS-CoV-2 have retracted their paper after acknowledging that their data were garbled.  The paper, “Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon,” appeared in the journal Viruses … Continue reading Ivermectin-COVID-19 study retracted; authors blame file mixup